Skip to main content
. 2017 Jul-Aug;92(4):546–549. doi: 10.1590/abd1806-4841.20174447

Table 1.

Liposarcoma classification

  Clinical Image (CT/NRM) Anatomopatho­logical Molecular characteristics Global survival rate Relapse rate / Metastasis rate
Atypical lipoma Painless, soft tu­mor. Slow growth. Most common locations: extremi­ties and retroper­itoneum. Most common subtype Encapsulated lipomatous mass (hyperintense in T1 and in T2 in NMR) with thick septations Proliferation of mature adipocytes, with size variation, focal nuclear atyp­ia, and/or fusiform cells Amplification of MDM-2 and CDK-4 76-93% (R) - 13-46% (extremities) (R) - 91% (retroperitone­um) (M) - almost zero
Undifferentiated LPS May result from an atypical lipoma (10%). More frequent in retroperitoneum and extremities Loss of signal in­tensity in images in T1 and focal nodules (>1 cm is suggestive) Abrupt transition between mature adipocytes and high degree non-li­pogenic sarcoma areas Amplification of MDM-2 and CDK-4 54-64% (R) - 18-57% (M) - 13-47%
Myxoid/ round cell LPS Tumors more common in lower limbs. Affects young adults more frequently Hypointensity of the signal in T1, and hyperin­tensity in T2 are pathognomonic Predominance of round cell myxoid stroma. There is vascular system of thin walls (plexi­form pattern) FUS-CHOP gene fusion. Mutations PI3K (20%) 40-75% (R) - 7-28% (M) - 10-58%
Pleomorphic LPS Rapid growth tumor. More frequent in old people and on extremities Nonspecific mass, with frequent necrosis and hem­orrhage necrosis Intense cell atypia, irregular lipoblast. Hyperchromatic nuclei Complex structural rearrangements 0-63% (R) - 16-45% (M) - 32-44%

Abbreviations: LPS=Liposarcoma; CT= Computed tomography; NMR= Nuclear magnetic resonance; RT=Radiotherapy